EMA — authorised 8 January 2018
- Marketing authorisation holder: Merck Sharp & Dohme Limited
- Status: approved
🇪🇺 Prevymis in European Union
EMA authorised Prevymis on 8 January 2018
Marketing authorisation
Prevymis in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is Prevymis approved in European Union?
Yes. EMA authorised it on 8 January 2018.
Who is the marketing authorisation holder for Prevymis in European Union?
Merck Sharp & Dohme Limited holds the EU marketing authorisation.